Olaf Stanger

2.5k total citations
62 papers, 1.8k citations indexed

About

Olaf Stanger is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Surgery. According to data from OpenAlex, Olaf Stanger has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 22 papers in Rheumatology and 14 papers in Surgery. Recurrent topics in Olaf Stanger's work include Folate and B Vitamins Research (21 papers), Cardiac Valve Diseases and Treatments (13 papers) and Aortic Disease and Treatment Approaches (8 papers). Olaf Stanger is often cited by papers focused on Folate and B Vitamins Research (21 papers), Cardiac Valve Diseases and Treatments (13 papers) and Aortic Disease and Treatment Approaches (8 papers). Olaf Stanger collaborates with scholars based in Austria, Switzerland and Germany. Olaf Stanger's co-authors include Martin Weger, Brian Fowler, Wilfried Renner, Wolfgang Herrmann, Jürgen Geisel, Klaus Pietrzik, Jutta Dierkes, Markus Stühlinger, Willibald Wonisch and O. Schmut and has published in prestigious journals such as Circulation, PLoS ONE and Stroke.

In The Last Decade

Olaf Stanger

59 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf Stanger Austria 26 702 363 349 294 263 62 1.8k
Süleyman Serdar Koca Türkiye 20 458 0.7× 315 0.9× 188 0.5× 103 0.4× 140 0.5× 110 1.6k
Gert Hein Germany 29 1.2k 1.7× 534 1.5× 387 1.1× 276 0.9× 94 0.4× 113 2.9k
Violetta Dziedziejko Poland 25 198 0.3× 679 1.9× 361 1.0× 125 0.4× 140 0.5× 166 2.4k
Günter Stein Germany 22 195 0.3× 314 0.9× 195 0.6× 130 0.4× 208 0.8× 67 1.8k
Ian McDowell United Kingdom 24 1.0k 1.4× 223 0.6× 548 1.6× 107 0.4× 259 1.0× 44 1.9k
Stuart J. Moat United Kingdom 29 1.4k 2.0× 631 1.7× 481 1.4× 196 0.7× 352 1.3× 80 2.8k
Barbara Voetsch United States 19 104 0.1× 250 0.7× 149 0.4× 443 1.5× 207 0.8× 35 1.9k
Raimund Hirschberg United States 33 235 0.3× 1.5k 4.1× 508 1.5× 532 1.8× 280 1.1× 81 4.3k
Sathnur Pushpakumar United States 25 296 0.4× 524 1.4× 196 0.6× 101 0.3× 238 0.9× 84 1.6k
Chul‐Hee Kim South Korea 30 95 0.1× 469 1.3× 367 1.1× 112 0.4× 324 1.2× 126 2.3k

Countries citing papers authored by Olaf Stanger

Since Specialization
Citations

This map shows the geographic impact of Olaf Stanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Stanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Stanger more than expected).

Fields of papers citing papers by Olaf Stanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Stanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Stanger. The network helps show where Olaf Stanger may publish in the future.

Co-authorship network of co-authors of Olaf Stanger

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Stanger. A scholar is included among the top collaborators of Olaf Stanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Stanger. Olaf Stanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tatzber, Franz, Wolfgang Schimetta, Irene Schmid, et al.. (2019). A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels. Oxidative Medicine and Cellular Longevity. 2019. 1–14. 34 indexed citations
2.
Stanger, Olaf, Brigitta Gahl, Sarah Longnus, et al.. (2016). Thrombocytopaenia after aortic valve replacement with stented, stentless and sutureless bioprostheses. European Journal of Cardio-Thoracic Surgery. 51(2). ezw295–ezw295. 17 indexed citations
3.
Stanger, Olaf, et al.. (2016). Freedom SOLO-Associated Thrombocytopaenia is Valve-Dependent and Not Due to In Vitro Pseudothrombocytopaenia. Heart Lung and Circulation. 26(3). 268–275. 3 indexed citations
4.
Stanger, Olaf, Volkhard Göber, Brigitta Gahl, et al.. (2015). The Freedom Solo pericardial stentless valve: Single-center experience, outcomes, and long-term durability. Journal of Thoracic and Cardiovascular Surgery. 150(1). 70–77. 10 indexed citations
5.
Thalmann, Markus, et al.. (2014). Clinical Experience With the Freedom SOLO Stentless Aortic Valve in 277 Consecutive Patients. The Annals of Thoracic Surgery. 98(4). 1301–1307. 15 indexed citations
6.
Stanger, Olaf. (2012). Water soluble vitamins : clinical research and future application. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 11 indexed citations
7.
Mueller, Edith E., Waltraud Eder, Danijela Šantić, et al.. (2011). The Mitochondrial T16189C Polymorphism Is Associated with Coronary Artery Disease in Middle European Populations. PLoS ONE. 6(1). e16455–e16455. 63 indexed citations
8.
Perła‐Kaján, Joanna, Olaf Stanger, Michał W. Łuczak, et al.. (2008). Immunohistochemical detection of N-homocysteinylated proteins in humans and mice. Biomedicine & Pharmacotherapy. 62(7). 473–479. 46 indexed citations
9.
Mossböck, Georg, Martin Weger, Christoph Faschinger, et al.. (2006). Methylenetetrahydrofolatereductase (MTHFR) 677C>T polymorphism and open angle glaucoma.. PubMed. 12. 356–9. 30 indexed citations
10.
Trummer, Olivia, H Köppel, Thomas C. Wascher, et al.. (2006). The serotonin transporter gene polymorphism is not associated with smoking behavior. The Pharmacogenomics Journal. 6(6). 397–400. 28 indexed citations
11.
Stühlinger, Markus & Olaf Stanger. (2005). Asymmetric Dimethyl-L-Arginine (ADMA): A Possible Link Between Homocyst(e)ine and Endothelial Dysfunction. Current Drug Metabolism. 6(1). 3–14. 75 indexed citations
12.
Stanger, Olaf, Jutta Dierkes, Brian Fowler, et al.. (2003). Konsensuspapier der D.A.CH.-Liga Homocystein über den rationellen klinischen Umgang mit Homocystein, Folsäure und B-Vitaminen bei kardiovaskulären und thrombotischen Erkrankungen - Richtlinien und Empfehlungen. Journal für Kardiologie (Krause & Pachernegg GmbH). 10(5). 190–199. 5 indexed citations
13.
Festa, Andreas, et al.. (2003). Adipositas und Herz: Neue Risikofaktoren und Surrogatendpunkte. Journal für Kardiologie (Krause & Pachernegg GmbH). 10(10). 409–417.
14.
Stanger, Olaf, Wolfgang Herrmann, Klaus Pietrzik, et al.. (2003). DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid and B-Vitamins in Cardiovascular and Thrombotic Diseases: Guidelines and Recommendations. Clinical Chemistry and Laboratory Medicine (CCLM). 41(11). 1392–403. 198 indexed citations
15.
Renner, Wilfried, et al.. (2002). The V34L polymorphism of factor XIII and peripheral arterial disease.. PubMed. 21(1). 53–7. 9 indexed citations
16.
Stanger, Olaf. (2002). Physiology of Folic Acid in Health and Disease. Current Drug Metabolism. 3(2). 211–223. 131 indexed citations
17.
Weger, Martin, Olaf Stanger, Hannes Deutschmann, et al.. (2002). Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefe s Archive for Clinical and Experimental Ophthalmology. 240(4). 286–290. 47 indexed citations
18.
Stanger, Olaf, et al.. (2002). Effects of Folate Treatment and Homocysteine Lowering on Resistance Vessel Reactivity in Atherosclerotic Subjects. Journal of Pharmacology and Experimental Therapeutics. 303(1). 158–162. 49 indexed citations
19.
20.
Stanger, Olaf, et al.. (2001). Vascular Dysfunction in Hyperhomocyst(e)inemia. Implications for Atherothrombotic Disease. Clinical Chemistry and Laboratory Medicine (CCLM). 39(8). 725–33. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Süleyman Serdar Koca Breakdown of academic impact, for papers by Gert Hein Breakdown of academic impact, for papers by Violetta Dziedziejko Breakdown of academic impact, for papers by Günter Stein Breakdown of academic impact, for papers by Ian McDowell Breakdown of academic impact, for papers by Stuart J. Moat Breakdown of academic impact, for papers by Barbara Voetsch Breakdown of academic impact, for papers by Raimund Hirschberg Breakdown of academic impact, for papers by Sathnur Pushpakumar Breakdown of academic impact, for papers by Chul‐Hee Kim
Rankless by CCL
2026